Kamada KMDA
NASDAQ KMDA
$8.31 +0.11 (+1.34%)
At close: Oct 2, 2026 · 4:00 PM EDT

Kamada (KMDA) Consolidated Net Income (2012 - 2026)

Updated

Kamada (KMDA) reported Consolidated Net Income of $9.26 million for the quarter ended Jun 30, 2026, up 25.6% from $7.38 million a year earlier and up 124.2% from the prior quarter.

Analysis

Kamada (KMDA) Consolidated Net Income (2012 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Kamada's Consolidated Net Income came in at $22.25 million, up 17.0% year-over-year; for the year ended Dec 31, 2025, it came in at $20.2 million, up 39.7% from the prior year.

  • Consolidated Net Income has a five-year compound annual growth rate of 3.3% (years ended Dec 2020 to Dec 2025).
  • By year, Consolidated Net Income came in at $14.46 million in the year ended Dec 31, 2024 (+74.6%), $8.28 million in the year ended Dec 31, 2023, -$2.32 million in the year ended Dec 31, 2022 and -$2.23 million in the year ended Dec 31, 2021.
  • The figure for the quarter ended Jun 30, 2026 ranks as the highest quarterly Consolidated Net Income since the quarter ended Dec 31, 2018.
  • Year over year, Consolidated Net Income gained in six of the last eight quarters, with growth averaging 23.7%.
  • The high point for year-over-year Consolidated Net Income in five years was the quarter ended Sep 30, 2023 (growth of 565.9%); the low point was the quarter ended Dec 31, 2024 (a decline of 24.7%).
  • Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $4.13 million (quarter ended Mar 31, 2026), $3.56 million (quarter ended Dec 31, 2025) and $5.3 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 5.53 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.62 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.51 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.50 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -237.00 Mn
10 Kamada 479.37 Mn 188.43 Mn 22.47 Mn 9.26 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.26 Mn
Mar 31, 2026 4.13 Mn
Dec 31, 2025 3.56 Mn
Sep 30, 2025 5.30 Mn
Jun 30, 2025 7.38 Mn
Mar 31, 2025 3.96 Mn
Dec 31, 2024 3.81 Mn
Sep 30, 2024 3.86 Mn
Jun 30, 2024 4.43 Mn
Mar 31, 2024 2.37 Mn
Dec 31, 2023 5.06 Mn
Sep 30, 2023 3.22 Mn
Jun 30, 2023 1.81 Mn
Mar 31, 2023 -1.81 Mn
Dec 31, 2022 2.94 Mn
Sep 30, 2022 484,000.00
Jun 30, 2022 -3.92 Mn
Mar 31, 2022 -1.83 Mn
Dec 31, 2021 -5.01 Mn
Sep 30, 2021 -845,000.00
API Access

Kamada Consolidated Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=KMDA&period=max&api_key=YOUR_API_KEY